Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dillon

Showing results (561-570 of 576) with videos related to

Pageof 58
Sort By:
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
JAMA Neurology|April 19, 2016
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer DiseaseJennifer S Yokoyama, Yunpeng Wang, Andrew J Schork, et al.
Plos Medicine|January 30, 2018
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studiesIris Broce, Celeste M Karch, Natalie Wen, et al.
Plos Medicine|January 10, 2018
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studiesIris Broce, Celeste M Karch, Natalie Wen, et al.
Molecular Cancer Therapeutics|November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug ResistanceKristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Circulation|February 24, 2025
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized TrialGregory M Marcus, Roderick Tung, Edward P Gerstenfeld, et al.
Journal of Medicinal Chemistry|March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced MalignanciesYing Huang, Martin Sendzik, Jeff Zhang, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload OptimizationAlexei S Karpov, Cristina M Nieto-Oberhuber, Tinya Abrams, et al.
Acta Neuropathologica|November 11, 2018
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's diseaseIris J Broce, Chin Hong Tan, Chun Chieh Fan, et al.
Pageof 58

Showing results (561-570 of 576) with videos related to

Sort By:
Pageof 58
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Journal of Medicinal Chemistry|January 17, 2017
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer EfficacyYing Huang, Jeff Zhang, Zhengtian Yu, et al.
JAMA Neurology|April 19, 2016
Association Between Genetic Traits for Immune-Mediated Diseases and Alzheimer DiseaseJennifer S Yokoyama, Yunpeng Wang, Andrew J Schork, et al.
Plos Medicine|January 30, 2018
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studiesIris Broce, Celeste M Karch, Natalie Wen, et al.
Plos Medicine|January 10, 2018
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studiesIris Broce, Celeste M Karch, Natalie Wen, et al.
Molecular Cancer Therapeutics|November 5, 2021
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug ResistanceKristen Jensen-Pergakes, John Tatlock, Karen A Maegley, et al.
Circulation|February 24, 2025
Left Ventricular Entry to Reduce Brain Lesions During Catheter Ablation: A Randomized TrialGregory M Marcus, Roderick Tung, Edward P Gerstenfeld, et al.
Journal of Medicinal Chemistry|March 30, 2022
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced MalignanciesYing Huang, Martin Sendzik, Jeff Zhang, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload OptimizationAlexei S Karpov, Cristina M Nieto-Oberhuber, Tinya Abrams, et al.
Acta Neuropathologica|November 11, 2018
Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer's diseaseIris J Broce, Chin Hong Tan, Chun Chieh Fan, et al.
Pageof 58